The recent approval of a blood test for diagnosing Alzheimer's disease by the Therapeutic Goods Administration (TGA) has raised questions regarding its efficacy and accessibility. While the test offers a less invasive method for detecting the disease, concerns persist about its accuracy and the potential for misdiagnosis.
News From Multiple Perspectives
Questioning the Efficacy and Accessibility of the New Alzheimer's Blood Test
Published July 30, 2026 at 6:02 AM UTC